CI vs IMNM · P/E 2.4, rev $274.90B vs rev $9.0M
Cigna Corp (CI) versus Immunome Inc (IMNM) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Immunome Inc (IMNM) is a biotechnology company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported IMNM revenue for 2024-12-31 was $9.0M. Net income was -$293.0M. Revenue was down 35.5% from 2023-12-31 to 2024-12-31. IMNM currently screens at market cap $2.47B.
CI currently screens at market cap $71.62B and trailing P/E 2.4. IMNM currently screens at market cap $2.47B.
Not investment advice. Open the CI and IMNM stock pages for the full models.
Not investment advice.